Dramamine Chewable Tablets for Kids- Grape

Manufacturer
Medtech Products Inc.
Effective date
2025-02-12
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:55:31

Label at a glance#

ProductDramamine for Kids
Active ingredientDIMENHYDRINATE
Label structure10 sections

Dosage and administration

To prevent motion sickness, the first dose should be taken ½ to 1 hour before starting activity To prevent or treat motion sickness see below: Children 2 to under 6 years   Give ½ to 1 chewable tablet every 6-8 hours  Do not give more than 3 chewable tablets in 24 hours or as directed by a doctor Children 6 to 12 years Give 1 to 2 chewable tablets every 6-8 hours Do not give more than 6 chewable tablets in 24 hour...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Dimenhydrinate 25mg

Purpose

OTC - PURPOSE SECTION

Antiemetic

Use

INDICATIONS & USAGE SECTION

for prevention and treatment of these symptoms associated with motion sickness:

  • nausea
  • dizziness
  • vomiting

Warnings

WARNINGS SECTION

Do not give to children under 2 years of age unless directed by a doctor.

Ask a doctor before use if the child has

OTC - ASK DOCTOR SECTION

  • a breathing problem such as emphysema or chronic bronchitis
  • glaucoma

Ask a doctor before use if the child is

OTC - ASK DOCTOR SECTION

taking sedatives or tranquilizers

When using this product

OTC - WHEN USING SECTION

  • marked drowsiness may occur
  • sedatives, and tranquilizers may increase drowsiness

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

  • To prevent motion sickness, the first dose should be taken ½ to 1 hour before starting activity
  • To prevent or treat motion sickness see below:
  • Children 2 to under 6 years Give ½ to 1 chewable tablet every 6-8 hours 
  • Do not give more than 3 chewable tablets in 24 hours or as directed by a doctor

Children 6 to 12 years

  • Give 1 to 2 chewable tablets every 6-8 hours
  • Do not give more than 6 chewable tablets in 24 hours, or as directed by a doctor

Other information

OTHER SAFETY INFORMATION

  • Phenylketonurics: contains phenylalanine 0.42 mg per tablet
  • Store at room temperature 20◦-25◦C (68◦-77◦F)
  • Do not use if blister is broken or torn

Inactive ingredients

INACTIVE INGREDIENT SECTION

aspartame, citric acid, flavors, magnesium stearate, methacrylic acid copolymer, sorbitol

Questions?

OTC - QUESTIONS SECTION

1-800-382-7219 Dramamine.com

Dist. by Medtech Products Inc., Tarrytown, NY 10591
A Prestige Consumer Healthcare company.
Made in Italy
©2024 Trade dress is owned by Medtech Products Inc. All rights reserved.
DAUS092101

Principal display panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Dramamine®
motion sickness
for Kids
CHEWABLE
DYE FREE
8 CHEWABLE TABLETS            
GRAPE FLAVOR

Dramamine® motion sickness for Kids CHEWABLE DYE FREE 8 CHEWABLE TABLETS GRAPE FLAVORDramamine® motion sickness for Kids CHEWABLE DYE FREE 8 CHEWABLE TABLETS GRAPE FLAVOR

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1245184dimenhyDRINATE 25 MG Chewable TabletPSN1
1245186Dramamine 25 MG Chewable TabletPSN1
1245186dimenhydrinate 25 MG Chewable Tablet [Dramamine]SBD1
1245184dimenhydrinate 25 MG Chewable TabletSCD1
1245186Dramamine 25 MG Chewable TabletSY1
1245186Dramamine for Kids 25 MG Chewable TabletSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
DIPHENHYDRAMINE Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0e2e0f88-b076-afe1-4bdd-32bca4375becProduct name320250127
e2db08c6-133f-4f4f-afb4-e90a2418d6f6Product name120230320
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906Product name720210625
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
11ed6f83-cdd2-4637-8379-b1a1d3ae3cdeProduct name120181101
86c45a79-b9f0-4476-a27c-6e10db098497Product name120180125
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
3e48c9c4-918d-5d23-2f0b-d2398b06be54Product name120140508
865c72dd-0d94-daac-f728-ddd4ded2a79eProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63029-908-08Dramamine for Kids8 in 1 BLISTER PACKTABLET, CHEWABLE81
63029-908-08Dramamine for Kids1 in 1 BOXTABLET, CHEWABLE11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63029-908DRAMAMINE FOR KIDS (DIMENHYDRINATE) TABLET, CHEWABLE [MEDTECH PRODUCTS INC.]1Current NDC, 2 package rows20250221_3ccd6eb4-ba7e-4a6a-abb9-a6ef3196240c.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63029-90863029-908-08

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Dramamine for KidsDIMENHYDRINATEMedtech Products Inc.3ccd6eb4-ba7e-4a6a-abb9-a6ef3196240c2025-02-12WarningsExact identifier
ndc (package): 63029-908-08
ndc (product): 63029-908
ndc11 (package): 63029090808
spl id: 46890832-3412-4d20-9c1a-0bd639ad618c
spl set id: 3ccd6eb4-ba7e-4a6a-abb9-a6ef3196240c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.